Statin Use Reduces Risk of Progression of Liver Fibrosis, Among Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial

被引：0
|
作者：
Simon, Tracey G.
King, Lindsay Y.
Zheng, Hui
Chung, Raymond T.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1026
引用
收藏
页码：S966 / S966
页数：1
相关论文
共 50 条
  • [21] Reversible Myopathy Induced By Long-Term Pegasys Mono Treatment for a Chronic Hepatitis C Patient under HALT-C Trial
    Cai, Chunyu
    Gioaccotto, Josh
    Felice, Kevin
    Grunnet, Margaret
    Whitaker, Charles
    Wu, Qian
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05): : 580 - 580
  • [22] Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial
    Fontana, RJ
    Bieliauskas, LA
    Back-Madruga, C
    Lindsay, KL
    Kronfol, Z
    Lok, AS
    Padmanabhan, L
    JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 614 - 622
  • [23] Retreatment of HCV non-responders with peginterferon and ribavirin: Results from the lead-in phase of the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) Trial
    Shiffman, M
    HEPATOLOGY, 2002, 36 (04) : 295A - 295A
  • [24] Herbal and milk thistle use in the halt-C trial of advanced chronic hepatitis C
    Seeff, Leonard B.
    Curto, Teresa M.
    Szabo, Gyongyi
    Everson, Gregory T.
    Bonkovsky, Herbert L.
    GASTROENTEROLOGY, 2007, 132 (04) : A789 - A789
  • [25] Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial
    Everson, Gregory T.
    Shiffman, Mitchell L.
    Hoefs, John C.
    Morgan, Timothy R.
    Sterling, Richard K.
    Wagner, David A.
    Lauriski, Shannon
    Curto, Teresa M.
    Stoddard, Anne
    Wright, Elizabeth C.
    HEPATOLOGY, 2012, 55 (04) : 1019 - 1029
  • [26] DNA polymorphisms and response to treatment in patients with chronic hepatitis C: Results from the HALT-C trial
    Morgan, Timothy R.
    Lambrecht, Richard W.
    Bonkovsky, Herbert L.
    Chung, Raymond T.
    Naishadham, Deepa
    Sterling, Richard K.
    Fontana, Robert J.
    Lee, William M.
    Ghany, Marc G.
    Wright, Elizabeth C.
    O'Brien, Thomas R.
    JOURNAL OF HEPATOLOGY, 2008, 49 (04) : 548 - 556
  • [27] Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
    Everhart, James E.
    Lok, Anna S.
    Kim, Hae-Young
    Morgan, Timothy R.
    Lindsay, Karen L.
    Chung, Raymond T.
    Bonkovsky, Herbert L.
    Ghany, Marc G.
    GASTROENTEROLOGY, 2009, 137 (02) : 549 - 557
  • [28] Dietary Cholesterol Intake is Associated with Liver Disease Progression in Hepatitis C Infection: Analysis of the HALT-C trial
    Yu, Lei
    Morishima, Chihiro
    Ioannou, George
    HEPATOLOGY, 2012, 56 : 647A - 648A
  • [29] Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial
    Everson, Gregory T.
    Hoefs, John C.
    Seeff, Leonard B.
    Bonkovsky, Herbert L.
    Naishadham, Deepa
    Shiffinan, Mitchell L.
    Kahn, Jeffrey A.
    Lok, Anna S. F.
    Di Bisceglie, Adrian M.
    Lee, William M.
    Dienstag, Jules L.
    Ghany, Marc G.
    Morishima, Chihiro
    HEPATOLOGY, 2006, 44 (06) : 1675 - 1684
  • [30] Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
    Simon, Tracey G.
    King, Lindsay Y.
    Zheng, Hui
    Chung, Raymond T.
    JOURNAL OF HEPATOLOGY, 2015, 62 (01) : 18 - 23
12345